On Wednesday, FDA announced plans to create a mobile surveillance application that could help health care workers monitor adverse drug effects during public health emergencies, NextGov reports.
About the App
Agency officials said the Real-Time Application for Portable Interactive Devices, or RAPID, would allow for portable, instantaneous reporting of drug reactions.
The app would let users collect video and images of patient reactions and record audio of medical histories. In addition, the app would display geographic trends of adverse drug events and map clusters of incidents using GPS data.
Plans for Implementation
FDA plans to test the app first on smartphones and then on tablet computers. The agency wants the app to be compatible with iPhones, Android-based phones and BlackBerry devices.
FDA said it plans to contract with a software developer that could build a fully operational prototype of the app within one year and develop a strategy for testing the app across the country (Sternstein, NextGov, 1/5).